Generative AI drug discovery breakthrough, with Alex Zhavoronkov
Alex Zhavoronkov, founder of Insilico Medicine, discusses the use of generative AI in drug discovery. He highlights how AI can identify novel drug targets and molecules, potentially reducing the time and cost of pharmaceutical development. The discussion covers AI-generated…